Patients using a specialty pharmacy for biotech medicines are more likely to report that they are better able to manage their condition than those using a retail pharmacy, according to a study released by PBM Express Scripts. Express Scripts conducted the study to determine the impact of the specialty pharmacy and its "high-touch" care model on RA patients. Consistent with the high-touch model, CuraScript patients were also more likely to perceive a greater level of skill among the specialty pharmacy staff and were more satisfied with the services provided versus retail, according to the study. NACDS declined to comment on the report.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.